ArticleCureus2025
Impact of Ventilation Tubes on Pediatric Otitis Media Outcomes: A Retrospective Study From Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAcute otitis media (AOM) and otitis media with effusion (OME) are common in children, often leading to hearing loss and developmental delay. Ventilation tubes (VTs) manage persistent middle ear effusions by draining fluid and reducing pressure, which can decrease AOM recurrence. METHODOLOGY: This retrospective cohort study reviewed the medical records of 388 pediatric patients at King Faisal Medical Complex, Saudi Arabia, from August 2021 to February 2024. Data on demographics, tympanometry results, treatment outcomes, and surgical interventions were collected. The data was analyzed using IBM SPSS Statistics for Windows, Version 26 (Released 2019; IBM Corp., Armonk, New York, United States). Categorical variables were reported as numbers and percentages, with descriptive statistics applied.
resultsAmong 388 children aged 2 to 12 years, girls predominated (56.2%). Tympanometry revealed bilateral type B in 64.4% and unilateral type B in 35.6%. After three months of observation and treatment, 47.6% were relieved, while 52.4% had persistent type B. Most cases were newly diagnosed (95.07%). Adenoid enlargement was observed in 86.70%, allergic rhinitis in 92.61%, and adeno-tonsillar enlargement in 68.47%. Surgical interventions included myringotomy only (15.27%), myringotomy with Shah tube (46.31%), and Shepard tube (38.42%). Complications were rare, with 88.18% achieving complete symptom relief and 4.93% partial relief during postoperative follow-up at 2 weeks, 3 months, 6 months, and 12 months.
conclusionVT effectively manages AOM and OME in children, with high rates of symptom relief. However, careful consideration of risks and follow-up is essential to optimize outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.